Intervention Review

Preoperative blood transfusions for sickle cell disease

  1. Ceri Hirst1,*,
  2. Lorna Williamson2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 18 JAN 2012

Assessed as up-to-date: 11 NOV 2011

DOI: 10.1002/14651858.CD003149.pub2

How to Cite

Hirst C, Williamson L. Preoperative blood transfusions for sickle cell disease. Cochrane Database of Systematic Reviews 2012, Issue 1. Art. No.: CD003149. DOI: 10.1002/14651858.CD003149.pub2.

Author Information

  1. 1

    AstraZeneca, Alderley Park, Cheshire, UK

  2. 2

    East Anglia Centre, National Blood Service, Cambridge, UK

*Ceri Hirst, AstraZeneca, Parklands (90HW2Q1), Alderley Park, Cheshire, SK10 4TG, UK.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 18 JAN 2012


Cited in:


This article has been cited by:

  1. 1
    Susan Hunt, Joseph Alisky, Inpatient Management of Sickle Cell Disease, Hospital Medicine Clinics, 2013, 2, 2, e247


  2. 2
    K. Ould Amar, J.-L. Rouvillain, G. Loko, Perioperative transfusion management in patients with sickle cell anaemia undergoing a total hip arthroplasty. Is there a role of red-cell exchange transfusion? A retrospective study in the CHU of Fort-de-France Martinique, Transfusion Clinique et Biologique, 2013, 20, 1, 30


  3. 3
    Jonathan C Goldsmith, Winfred C Wang, Preoperative transfusion in patients with sickle-cell disease, The Lancet, 2013, 381, 9870, 886


  4. 4
    Jo Howard, Moira Malfroy, Charlotte Llewelyn, Louise Choo, Renate Hodge, Tony Johnson, Shilpi Purohit, David C Rees, Louise Tillyer, Isabeau Walker, Karin Fijnvandraat, Melanie Kirby-Allen, Eldon Spackman, Sally C Davies, Lorna M Williamson, The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial, The Lancet, 2013, 381, 9870, 930